1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > OTC Triptans in Sweden

OTC Triptans in Sweden

  • April 2013
  • -
  • Euromonitor International
  • -
  • 24 pages

The most likely customer of OTC triptans products in Sweden suffers from migraines but has not been diagnosed by a medical professional. The growing self-medication trend is therefore a key driver of sales and value growth in 2012.

Euromonitor International's OTC Triptans in Sweden report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the OTC Triptans market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

OTC Triptans in Sweden
OTC TRIPTANS IN SWEDEN
Euromonitor International
April 2013

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of OTC Triptans: Value 2008-2012
Table 2 Sales of OTC Triptans: % Value Growth 2008-2012
Table 3 OTC Triptans Company Shares by Value 2008-2012
Table 4 OTC Triptans Brand Shares by Value 2009-2012
Table 5 Forecast Sales of OTC Triptans: Value 2012-2017
Table 6 Forecast Sales of OTC Triptans: % Value Growth 2012-2017
Executive Summary
Positive Value Growth for Consumer Health
Self-medication Trend Is A Key Theme
Multinationals Dominate in A Competitive Environment
Chemists/pharmacies Still Dominate Shifting Distribution Landscape
Continued Value Growth Expected
Key Trends and Developments
Deregulation Sparks Heated Debate
Rapid Slowdown in the Swedish Economy
the Impact of the Ageing Population
Increased Competition Means Hard Times for Pharmacy Retailers
Self-medication Drives Value Growth
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Penetration of Private Label by Category 2007-2012
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
European Regulatory Systems
Marketing Authorisations
Advertising
Standardised Packaging Requirements
Vitamins and Dietary Supplements Registration and Classification
Distribution
Regulation of Vitamins and Dietary Supplements
Regulation of Herbal Products
Advertising
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2010-2012
Definitions
Sources
Summary 2 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

  • $ 6650
  • Industry report
  • March 2017
  • by BCC Research

Use this report to: - Receive information concerning the dynamics and forecasts in the OTC drugs and dietary supplements market - Receive information pertaining to the major regional trends in the global ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Industry in the US

  • March 2017
    89 pages
  • OTC  

  • United States  

View report >

OTC Supply in the US

  • March 2017
  • Dietary Supplem...  

  • United States  

View report >

OTC Industry in China and the US

  • March 2017
    57 pages
  • Vitamin  

  • China  

    United States  

View report >

Otc Markets In Europe

19 days ago

Otc Industry In China

20 days ago

Otc Markets In Canada

21 days ago

Related Market Segments :

OTC

ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.